In the article on optimized Fc regions for tumor treatment in the September 15, 2007 issue of Cancer Research (1), Dr. Sujata Vijh should have been included as the eighth author. Dr. Vijh's affiliation is Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.

1
Stavenhagen JB, Gorlatov S, Tuaillon N, Rankin CT, Li H, Burke S, Huang L, Vijh S, Johnson S, Bonvini E, Koenig S. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcγ receptors.
Cancer Res
 
2007
;
67
:
8882
–90.
View Original Article
©2008 American Association for Cancer Research.
2008